Jauregi Zinkunegi, A, Gleason, CE, Bendlin, B, Okonkwo, O, Hermann, BP, Blennow, K, Zetterberg, H, Hogervorst, E, Johnson, SC, Langhough, R, Mueller, KD and Bruno, D (2025) Menopausal hormone therapy is associated with worse levels of Alzheimer’s disease biomarkers in APOE4-carrying women: An observational study. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. pp. 1-13. ISSN 1552-5260
|
Text
Menopausal hormone therapy is associated with worse levels of Alzheimers disease biomarkers.pdf - Published Version Available under License Creative Commons Attribution. Download (737kB) | Preview |
Abstract
INTRODUCTION: Menopausal hormone therapy (MHT), along with the apolipoprotein E (APOE) ε4 allele, has been suggested as a possible risk factor for Alzheimer’s disease (AD). However, the relationship between MHT and cerebrospinal fluid (CSF) biomarkers is unknown: we investigated this association, and whether APOE4 carrier status moderates it. METHODS: In an observational study of 134 cognitively unimpaired female participants (Mage=66.1; SD=6.3), we examined whether MHT use alone or in interaction with APOE4 carrier status was associated with CSF levels of ptau, Aβ40, Aβ42, p-tau/Aβ42 and Aβ42/40 ratios. RESULTS: Significant interactions were found between APOE4 and MHT use for CSF biomarkers. APOE4 carriers who were MHT users showed worse levels of CSF p-tau/Aβ42 and Aβ42/40 ratios, than all other users and non-users. DISCUSSION: The presence of both APOE4 and MHT may be associated with elevated amyloid deposition and AD pathology in this sample of participants who demonstrated high familial AD risk.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 1103 Clinical Sciences; 1109 Neurosciences; Geriatrics |
Subjects: | B Philosophy. Psychology. Religion > BF Psychology R Medicine > R Medicine (General) R Medicine > RG Gynecology and obstetrics |
Divisions: | Psychology (from Sep 2019) |
Publisher: | Wiley |
SWORD Depositor: | A Symplectic |
Date Deposited: | 03 Dec 2024 14:39 |
Last Modified: | 09 Jan 2025 13:30 |
DOI or ID number: | 10.1002/alz.14456 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/24986 |
View Item |